Werewolf Therapeutics (HOWL) Payables (2020 - 2026)

Werewolf Therapeutics (HOWL) has reported Payables for 7 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 62.52% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a 62.52% decrease from a year earlier, with the FY2025 full-year figure at $29.0 million, up 855.19% from the prior year.
• Payables was $1.9 million for Q2 2026 at Werewolf Therapeutics, down from $32.4 million in the prior quarter.
• Over five years, Payables peaked at $32.4 million in Q1 2026 and troughed at $986000.0 in Q1 2025.
• A 5-year average of $6.5 million and a median of $2.3 million in 2022 frame the typical range for Payables.
• Across the five-year window, Payables sank 92.56% in 2025 and soared 3186.0% in 2026, its largest moves.
• Over 5 years, Payables stood at $1.2 million in 2022, then jumped by 555.45% to $8.0 million in 2023, then tumbled by 62.08% to $3.0 million in 2024, then soared by 855.19% to $29.0 million in 2025, then sank by 93.31% to $1.9 million in 2026.
• The last three Payables figures came in at $1.9 million (Q2 2026), $32.4 million (Q1 2026), and $29.0 million (Q4 2025), per Business Quant data.